Lucas Bethge
Vice President & Group Lead - Oligonucleotide Chemistry Silence Therapeutics
Seminars
Thursday 19th March 2026
Expanding Bioconjugate Applications into Immunology & Inflammatory Disease
12:00 pm
- Applying conjugate technology to autoimmune and fibrotic conditions
- Exploring payload classes with immune-modulating potential
- Understanding translational challenges beyond oncology targets
